Johnson Health Tech .Co., Ltd. (TPE: 1736)
Taiwan
· Delayed Price · Currency is TWD
144.50
-1.50 (-1.03%)
Nov 21, 2024, 9:12 AM CST
Johnson Health Tech .Co. Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 43,131 | 38,070 | 33,613 | 30,779 | 28,367 | 25,373 | Upgrade
|
Revenue Growth (YoY) | 17.08% | 13.26% | 9.21% | 8.50% | 11.80% | 16.62% | Upgrade
|
Cost of Revenue | 21,304 | 19,642 | 19,007 | 16,873 | 14,969 | 12,826 | Upgrade
|
Gross Profit | 21,827 | 18,427 | 14,606 | 13,906 | 13,397 | 12,547 | Upgrade
|
Selling, General & Admin | 18,318 | 15,986 | 13,890 | 12,559 | 11,630 | 10,304 | Upgrade
|
Research & Development | 1,149 | 1,062 | 913.22 | 808.65 | 785.54 | 650.65 | Upgrade
|
Operating Expenses | 19,521 | 17,185 | 14,821 | 13,752 | 12,467 | 11,054 | Upgrade
|
Operating Income | 2,306 | 1,242 | -214.93 | 154.19 | 930.09 | 1,493 | Upgrade
|
Interest Expense | -369.8 | -377.47 | -256.18 | -163.48 | -163.23 | -158.02 | Upgrade
|
Interest & Investment Income | 284.94 | 194.19 | 165.17 | 152.41 | 180.44 | 277.98 | Upgrade
|
Currency Exchange Gain (Loss) | 363.44 | 363.44 | 970.59 | -96.88 | -265.71 | -75.34 | Upgrade
|
Other Non Operating Income (Expenses) | -385.17 | -63.71 | -132.27 | 90.84 | 308.49 | 51.95 | Upgrade
|
EBT Excluding Unusual Items | 2,199 | 1,359 | 532.38 | 137.08 | 990.07 | 1,590 | Upgrade
|
Gain (Loss) on Sale of Investments | -15.23 | -15.23 | -226.39 | 23.18 | -6.8 | -3 | Upgrade
|
Gain (Loss) on Sale of Assets | -9.05 | -9.05 | -2.38 | 3.44 | -7.94 | 30.47 | Upgrade
|
Pretax Income | 2,175 | 1,334 | 303.61 | 163.7 | 975.33 | 1,617 | Upgrade
|
Income Tax Expense | 892.87 | 625.05 | 78.67 | 64.33 | 227.98 | 323.18 | Upgrade
|
Earnings From Continuing Operations | 1,282 | 709.44 | 224.94 | 99.37 | 747.35 | 1,294 | Upgrade
|
Minority Interest in Earnings | 0.29 | 0.39 | 204.08 | -61.22 | -68.06 | -1.49 | Upgrade
|
Net Income | 1,283 | 709.83 | 429.02 | 38.15 | 679.29 | 1,293 | Upgrade
|
Net Income to Common | 1,283 | 709.83 | 429.02 | 38.15 | 679.29 | 1,293 | Upgrade
|
Net Income Growth | 117.31% | 65.45% | 1024.63% | -94.38% | -47.44% | 231.60% | Upgrade
|
Shares Outstanding (Basic) | 308 | 303 | 303 | 303 | 303 | 303 | Upgrade
|
Shares Outstanding (Diluted) | 308 | 303 | 303 | 303 | 303 | 303 | Upgrade
|
Shares Change (YoY) | 1.75% | 0.10% | 0.01% | -0.02% | -0.25% | 0.10% | Upgrade
|
EPS (Basic) | 4.16 | 2.34 | 1.42 | 0.13 | 2.24 | 4.26 | Upgrade
|
EPS (Diluted) | 4.16 | 2.34 | 1.42 | 0.13 | 2.24 | 4.26 | Upgrade
|
EPS Growth | 113.40% | 65.06% | 1024.49% | -94.37% | -47.42% | 231.28% | Upgrade
|
Free Cash Flow | 1,333 | 3,193 | -15.32 | -4,229 | 2,160 | 295.73 | Upgrade
|
Free Cash Flow Per Share | 4.33 | 10.54 | -0.05 | -13.98 | 7.14 | 0.97 | Upgrade
|
Dividend Per Share | - | 0.999 | 0.600 | 0.500 | 1.120 | 1.400 | Upgrade
|
Dividend Growth | - | 66.46% | 20.00% | -55.36% | -20.00% | 115.38% | Upgrade
|
Gross Margin | 50.61% | 48.40% | 43.45% | 45.18% | 47.23% | 49.45% | Upgrade
|
Operating Margin | 5.35% | 3.26% | -0.64% | 0.50% | 3.28% | 5.88% | Upgrade
|
Profit Margin | 2.97% | 1.86% | 1.28% | 0.12% | 2.39% | 5.09% | Upgrade
|
Free Cash Flow Margin | 3.09% | 8.39% | -0.05% | -13.74% | 7.62% | 1.17% | Upgrade
|
EBITDA | 2,992 | 1,812 | 323.24 | 637.49 | 1,318 | 1,850 | Upgrade
|
EBITDA Margin | 6.94% | 4.76% | 0.96% | 2.07% | 4.64% | 7.29% | Upgrade
|
D&A For EBITDA | 686 | 569.66 | 538.17 | 483.3 | 387.52 | 356.69 | Upgrade
|
EBIT | 2,306 | 1,242 | -214.93 | 154.19 | 930.09 | 1,493 | Upgrade
|
EBIT Margin | 5.35% | 3.26% | -0.64% | 0.50% | 3.28% | 5.88% | Upgrade
|
Effective Tax Rate | 41.05% | 46.84% | 25.91% | 39.30% | 23.37% | 19.98% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.